1.HPLC Fingerprint of Fructus Polygoni Orientalis
Yanjun ZHAI ; Yuantong ZHANG ; Jing HE ; Xiaolei HUO ; Tingguo KANG
Chinese Traditional Patent Medicine 1992;0(08):-
AIM:In order to ensure the quality stability of Fructus Polygoni Orientalis,to study the determination method of the fingerprint of Fruetus Polygoni Orientalis and to establish the fingerprint of Fructus Polygoni Orientalis.METHODS:The HPLC assay was used to establish the fingerprint of Fructus Polygoni Orienlalis and 28 pieces of goods were compared.RESULTS:The fingerprint of Fructus Polygoni Orientalis with 7 common peaks was established.The relative retention time and the ranges of relative area of the common peaks were determined.CONCLUSION:The established fingerprint can be used for the quality control of Fructus Polygoni Orientalis.
2.LIMP-2 enhances cancer stem-like cell properties by promoting autophagy-induced GSK3β degradation in head and neck squamous cell carcinoma.
Yuantong LIU ; Shujin LI ; Shuo WANG ; Qichao YANG ; Zhizhong WU ; Mengjie ZHANG ; Lei CHEN ; Zhijun SUN
International Journal of Oral Science 2023;15(1):24-24
Cancer stem cell-like cells (CSCs) play an integral role in the heterogeneity, metastasis, and treatment resistance of head and neck squamous cell carcinoma (HNSCC) due to their high tumor initiation capacity and plasticity. Here, we identified a candidate gene named LIMP-2 as a novel therapeutic target regulating HNSCC progression and CSC properties. The high expression of LIMP-2 in HNSCC patients suggested a poor prognosis and potential immunotherapy resistance. Functionally, LIMP-2 can facilitate autolysosome formation to promote autophagic flux. LIMP-2 knockdown inhibits autophagic flux and reduces the tumorigenic ability of HNSCC. Further mechanistic studies suggest that enhanced autophagy helps HNSCC maintain stemness and promotes degradation of GSK3β, which in turn facilitates nuclear translocation of β-catenin and transcription of downstream target genes. In conclusion, this study reveals LIMP-2 as a novel prospective therapeutic target for HNSCC and provides evidence for a link between autophagy, CSC, and immunotherapy resistance.
Humans
;
Autophagy
;
Carcinoma, Squamous Cell/pathology*
;
Cell Line, Tumor
;
Glycogen Synthase Kinase 3 beta/metabolism*
;
Head and Neck Neoplasms/pathology*
;
Neoplastic Stem Cells/pathology*
;
Squamous Cell Carcinoma of Head and Neck/pathology*
;
Lysosome-Associated Membrane Glycoproteins